BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Garg A, Patel B, Abbara A, Dhillo WS. Treatments targeting neuroendocrine dysfunction in polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 2022. [PMID: 35262967 DOI: 10.1111/cen.14704] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Constantin S. Targeting KNDy neurons to control GnRH pulses. Current Opinion in Pharmacology 2022;67:102316. [DOI: 10.1016/j.coph.2022.102316] [Reference Citation Analysis]
2 Zhang L, Fernando T, Liu Y, Liu Y, Zhu X, Li M, Shi Y. Neurokinin 3 receptor antagonist-induced adipocyte activation improves obesity and metabolism in PCOS-like mice. Life Sciences 2022;310:121078. [DOI: 10.1016/j.lfs.2022.121078] [Reference Citation Analysis]
3 Shi YQ, Wang Y, Zhu XT, Yin RY, Ma YF, Han H, Han YH, Zhang YH. The Application of Complementary and Alternative Medicine in Polycystic Ovary Syndrome Infertility. Evid Based Complement Alternat Med 2022;2022:5076306. [PMID: 36248406 DOI: 10.1155/2022/5076306] [Reference Citation Analysis]
4 Abbara DA. Editorial for Clinical Endocrinology Special Issue on Polycystic Ovary Syndrome (PCOS). Clin Endocrinol (Oxf) 2022. [PMID: 35731025 DOI: 10.1111/cen.14791] [Reference Citation Analysis]